Literature DB >> 15709779

Biochemical characterization of domains in the membrane subunit DrrB that interact with the ABC subunit DrrA: identification of a conserved motif.

Parjit Kaur1, Divya K Rao, Suvarna M Gandlur.   

Abstract

DrrA and DrrB proteins confer resistance to the commonly used anticancer agents daunorubicin and doxorubicin in the producer organism Streptomyces peucetius. The drrAB locus has previously been cloned in Escherichia coli, and the proteins have been found to be functional in this host. DrrA, a soluble protein, belongs to the ABC family of proteins. It forms a complex with the integral membrane protein DrrB. Previous studies suggest that the function and stability of DrrA and DrrB are biochemically coupled. Thus, DrrA binds ATP only when it is in a complex with DrrB in the membrane. Further, DrrB is completely degraded if DrrA is absent. In the present study, we have characterized domains in DrrB that may be directly involved in interaction with DrrA. Several single-cysteine substitutions in DrrB were made. Interaction between DrrA and DrrB was studied by using a cysteine to amine chemical cross-linker that specifically cross-links a free sulfhydryl group in one protein (DrrB) to an amine in another (DrrA). We show here that DrrA cross-links with both the N- and the C-terminal ends of the DrrB protein, implying that they may be involved in interaction. Furthermore, this study identifies a motif within the N-terminal cytoplasmic tail of DrrB, which is similar to a motif recently shown by crystal structure analysis in BtuC and previously shown by sequence analysis to be also present in exporters, including MDR1. We propose that the motif present in DrrB and other exporters is actually a modified version of the EAA motif, which was originally believed to be present only in the importers of the ABC family. The present work is the first report where domains of interaction in the membrane component of an ABC drug exporter have been biochemically characterized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709779     DOI: 10.1021/bi048959c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  The extreme C terminus of the ABC protein DrrA contains unique motifs involved in function and assembly of the DrrAB complex.

Authors:  Han Zhang; Prajakta Pradhan; Parjit Kaur
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

2.  Improvement of macrolactins production by the genetic adaptation of Bacillus siamensis A72 to saline stress via adaptive laboratory evolution.

Authors:  Yuman Gan; Meng Bai; Xiao Lin; Kai Liu; Bingyao Huang; Xiaodong Jiang; Yonghong Liu; Chenghai Gao
Journal:  Microb Cell Fact       Date:  2022-07-19       Impact factor: 6.352

Review 3.  Structure, function, and evolution of bacterial ATP-binding cassette systems.

Authors:  Amy L Davidson; Elie Dassa; Cedric Orelle; Jue Chen
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

4.  Conformational changes in a multidrug resistance ABC transporter DrrAB: Fluorescence-based approaches to study substrate binding.

Authors:  Sadia J Rahman; Parjit Kaur
Journal:  Arch Biochem Biophys       Date:  2018-09-20       Impact factor: 4.013

5.  Characterization of plasmids in a human clinical strain of Lactococcus garvieae.

Authors:  Mónica Aguado-Urda; Alicia Gibello; M Mar Blanco; Guillermo H López-Campos; M Teresa Cutuli; José F Fernández-Garayzábal
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

6.  Characterization of Regulatory and Transporter Genes in the Biosynthesis of Anti-Tuberculosis Ilamycins and Production in a Heterologous Host.

Authors:  Jianqiao He; Xin Wei; Zhijie Yang; Yan Li; Jianhua Ju; Junying Ma
Journal:  Mar Drugs       Date:  2020-04-17       Impact factor: 5.118

7.  Molecular cloning and functional characterization of an ATP-binding cassette transporter OtrC from Streptomyces rimosus.

Authors:  Lan Yu; Xiangyun Yan; Long Wang; Ju Chu; Yingping Zhuang; Siliang Zhang; Meijin Guo
Journal:  BMC Biotechnol       Date:  2012-08-20       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.